AS an attempt to elucidate further the pathogenesis of human cytomegalovirus (HCMV) infection the replication of HCMV in primary human bone marrow cells (BMC) has been investigated. It was found that BMC held in culture in general were susceptible to HCMV infection. Compared to human embryonic lung cells, however, the replicative cycle of HCMV AD169 in BMC as determined by the analysis of viral protein and DNA synthesis was delayed and productive virus infection was restricted to a subset of BMC not exceeding 21% of the total cell population. Both of these phenomena may explain the short-term persistence of HCMV in BMC cultures which was observed over 3 months. By experiments with specifically enriched and depleted cell populations and by indirect double immunofluorescence experiments we found that both bone marrow fibroblasts and a subset of bone marrow stem cells supported productive virus infection. The finding that HCMV replicates in early stem cells of the human bone marrow may explain important aspects of the pathogenesis of HCMV infection including the presence of HCMV in peripheral blood leukocytes.
INTRODUCTION
Human cytomegalovirus (HCMV) has been frequently isolated from human leukocytes and their subsets as reported from different laboratories throughout the last 10 years (Harnden et al., 1967; Fiala et at., 1975; Rinaldo et aL, 1977; Macher et al., 1983 ; summarized by Kirchner, 1983) . Positive results of virus isolation were most frequently achieved by co-cultivation of human granulocytes with indicator cells, suggesting that the granulocyte cell fraction is one of the major virus reservoirs (Fiala et al., 1975 ; Rinaldo et aL, 1980) . Attempts to cultivate HCMV in vitro in primary human polymorphonuclear or mononuclear cells, however, were not successful and even infection of progenitor cell lines such as myeloblastoid lines did not lead to any appreciable virus replication (Rinaldo et al., 1978 ; Einhorn & Ost, 1984) , The recent finding of HCMV RNA in lymphocytes of naturally infected individuals (Schrier et al., 1985) would suggest the possibility that HCMV does replicate in lymphocytes in vivo. These results, however, would not exclude the possibility that virus replication can also occur in early stem cells of the human bone marrow (Hirsch, 1984) . The latter theory is supported by the finding that HCMV patients frequently show alterations of bone marrow cells (BMC) especially thrombocytopenia (Verdonck et al., 1985) , and that in generalized infections the presence of HCMV can be demonstrated in the bone marrow (Brunning, 1981 ; Bodem et al., 1983) . Furthermore, HCMV infection is the most frequent disease observed after bone marrow transplantation (Neimann et al., 1977) and the reported T cell subset alterations after HCMV infection (Carney et al., 1981) may well be explained by replication of the virus in early stem cells. Moreover, several reports on the replication of HCMV in different erythroleukaemic and lymphoblastoid cell lines in vitro suggest a susceptibility to HCMV of immature cells rather than of finally differentiated cell I" Present address: Department of Pathology, Harvard Medical School, Boston, Massachusetts, U.S.A. (Joncas et al., 1975; Furukawa,1979) . For these reasons we investigated whether primary human BMC are susceptible to HCMV infection and if this replication involves primary stem cells.
0000-7163 © 1986 SGM

METHODS
Virus and viral growth. For preparation of virus stocks human embryonic Dung cells (HEL) WI-38 were used. Cells were held in Basal Medium Eagle (BM E) containing 10 ~ foetal calf serum (FCS), 100 units/ml penicillin, 100 pg/ml streptomycin and were grown at 37 °C in a humidified atmosphere containing 5~ CO2. Three days after subcultivation cells were infected with HCMV strain AD169 at a low m.o.i. (0.01 p.f.u./cell) to avoid generation of defective particles (DeMarchi & Kaplan, 1977) and supernatant virus was harvested 10 days after infection. As kindly tested by Dr W. Nicklas, German Cancer Research Center, Heidelberg, cells and virus were free of mycoplasma contamination. For mycoplasma testing, samples of virus and cell suspensions were cultured for 7 to l0 days in PPLO broth (Difco) containing 10~ yeast lysate and 20~ horse serum. Subsequently, portions of these cultures were grown on PPLO agar (Difco) supplemented with 20% horse serum and 10% yeast lysate. Petri dishes were microscopically examined for mycoplasma growth twice a week.
Virus titrations were performed on HEL cells with an overlay of 0.3 ~ agarose (Sigma) in BME and 10% FCS for 10 days at 37 °C in a humidified atmosphere. Infectious centre assays were performed in a modification of a procedure developed for herpes simplex virus which takes into account the trypsin resistance of HCMV (Rapp, 1984) . Thus, bone marrow cells were infected with HCMV ADI69 at an m.o.i, of 5 p.f.u./cell. Following 2 h incubation at 37 °C cells were thoroughly washed and cultivated as outlined below. Five days after infection when the input virus was heat-inactivated, cells were washed again and mixed in serial dilutions with HEL indicator cells. Cells were seeded in Petri dishes and when attached overlaid with 0.3 ~ agarose in BME and FCS. Cultures were monitored for the appearance of c.p.e, every second day and were re-fed weekly. Fourteen to 16 days after cultivation the cells were fixed with 3.5~ formaldehyde and stained with 0.1 ~ crystal violet. The method was shown to yield approximately 97~ infectious centres on isogenous cells.
Bone marrow cells. Primary human BMC were isolated from sternal punch biopsies. The heparinized bone marrow biopsies were layered onto metrizoate/Ficoll gradients (Lymphoprep; Nyegaard, Oslo, Norway) to remove contaminating erythrocytes and centrifuged for 30 min at 400 g. Cells in the supernatant were isolated and washed twice and subsequently cultivated in a medium for long-term maintenance of BMC modified from Gartner & Kaplan (1980) at a density of 5 × 105 cells per ml. This medium consisted of RPMI 1640 supplemented with 12.5~ heat-inactivated FCS, 12-5% heat-inactivated horse serum, 1 mM-L-glutamine, 10 p.g/ml fl-alanine, 100 IU/ml penicillin G and 100 btg/ml streptomycin. Cells were re-fed weekly by removal of the supernatant, centrifugation of the supernatant cells and readdition of these cells suspended in fresh growth medium to the adherent layer. The outgrowth of adherent cells was observed after 1 week of culture. To separate human bone marrow stem cells from differentiated cells and fibroblasts, a combination of plastic adherence and indirect rosetting with the monoclonal antibody OKT10 was used. OKT10 has earlier been shown to react with early human haematopoietic stem cells Greaves, 1981 ; Crawford et al., 1981) . BMC purified as described above were first cultivated in growth medium for 7 days in plastic flasks (Falcon) to allow fibroblasts to attach to the solid phase. The remaining supernatant cells were then labelled with OKTI0 and OKT10-positive cells were separated by indirect rosetting with goat anti-mouse IgG-coupled erythrocytes as previously described . OKT10 ÷ cells and OKTI0-cells were further cultivated in growth medium for 10 days and subsequently infected with HCMV ADI69 at an m.o.i, of 2 p.f.u./cell. Virus titrations were performed using the supernatants of the cultures.
Antibodies and immunofluorescence techniques. As antibodies against HCMV late antigens a high titre (/> 1000) human convalescent serum was used. Human serum was preabsorbed to n0n-infected HEL cells in order to avoid non-specific reactions with human BMC. The specificity of antibodies was proved by using mock-infected HEL cells, mock-infected BMC, and on HEL cells infected with HCMV at an m.o.i, of 0.1 p.f.u./cell for 48 h. OKT10 was used as an antibody specifically directed against bone marrow stem ceils.
Indirect immunofluorescence on HCMV-infected BMC was performed as described previously (Schober et al., 1984) . In brief, acetone-fixed BMC were labelled with the respective antibody at 4 °C in 0.1 M-phosphate-buffered saline and 1 ~ FCS to cover possible Fc-receptors. Subsequently, cells were thoroughly washed and incubated with a fluorescein isothiocyanate (FITC)-coupled goat anti-human IgG F(ab')2 fragment (Medac, Hamburg, F.R.G.). Mock-infected BMC and HCMV-infected HEL cells served as controls for specificity.
SDS-polyacrylamide gel electrophoresis. SDS-PAGE was performed essentially as described by Thomas & Kornberg (1975) . Approximately 3 × l0 s mock-infected and HCMV-infected BMC and HEL cells (m.o.i. 3 p.f.u./cell) were washed three times in Tris-buffered saline (TBS; 0.05 M-Tris-HC1 pH 7.4, 0-15 M-NaC1) and were boiled for 3 min in sample buffer (0.0625 M-Tris HCI pH 6.8, 2~ SDS, 10~ glycerol, 5~ 2-mercaptoethanol, 0.001 ~ bromophenol blue). 10~ polyacrylamide gels were run as 0.75 mm slab gels. Internal molecular weight standards were carbonic anhydrase (mol. wt. 29000), ovalbumin (mol. wt. 45000), albumin (mol. wt. 66000) and phosphorylase B (mol. wt. 97400), all purchased from New England Nuclear.
After fixation in 10~ TCA gels were silver-stained according to Switzer et al. (1979) and Oakley et al. (1980) . Dot blot hybridization. Dot blot hybridizations were performed in a modified version of a procedure previously described (Brandsma & Miller, 1980; McDonough & Spector, 1983; Spector et al., 1984) . The DNA of approx. 106 HCMV-infected BMC was spotted on nitrocellulose filters pre-activated in 20 x SSC (SSC is 0.15 M-NaCI, 0"015 M-sodium citrate). Filters were subsequently soaked in 0.1 M-HCI for 2 min, then for a further two 15 min periods in 0.5 M-NaOH, neutralized twice in 1 M-TBS pH 7.4 (1 M-Tris-HCI pH 6.8, 0.6 M-NaC1) for 2 min, once in 0.5 ta-Tris-HCl pH 7.4 and 1.2 M-NaCI for 7 min, and baked for 3 h at 80 °C in a vacuum oven. Prehybridization was for 3 h in 6 x SSC, 0.5~ SSC, 0.5~ SDS, 5 x Denhardt's solution and 100 lag/ml herring sperm DNA at 68 °C. Hybridization was under the same conditions with 0.002 M-EDTA and 80 ng/ml of 32p-labelled nick-translated cloned HCMV DNA (sp. act. 108 c.p.m/~tg). HCMV clones having no cross-hybridizing activity to the cellular genome (Rfiger et al., 1984) were kindly obtained from Drs B. Fleckenstein and R. Rfiger, Institut fiir Klinische Virologic, Universitat Erlangen, F.R.G. Cosmids used as probes in equimolar amounts were pCM3, pCM52, pCM 104, pCM5018, pCM5009, pCM5004, pCM5003, pCM5002 and pRR3. Washing was for four 5 min periods in 2 x SSC, 0.1~ SDS at room temperature and then for 3 h in 0.2 x SSC, 0.1~ SDS at 68°C. Subsequently filters were dried and exposed to Kodak XAR-5 films. Following autoradiography the single dots were cut out and radioactivity was counted in a liquid scintillation spectrophotometer.
RESULTS
When human BMC were cultivated under the conditions described above, after 3 to 5 days the outgrowth of fibroblasts and subsequently the formation of cobblestone areas of haematopoiesis was observed as described earlier by Gartner & Kaplan (1980) . A typical picture of such a culture is given in Fig. 1 (b) , in which different bone marrow stem cells and among these single fibroblast-like cells are shown. Primary BMC without any precultivation, however, did not show any adherent cells (Fig. 1 a) . To prove in general the capacity of such primary human BMC cultures to replicate HCMV, freshly isolated BMC and BMC cultivated for 3 weeks, when cobblestone areas of haematopoiesis became visible, were infected with HCMV AD169 at an m.o.i, of 2 and were monitored for the appearance of a c.p.e, and virus production. As shown in Fig. 1 (c) typical c.p.e, with inclusion bodies developed in precultivated BMC from day 8 after infection and progeny virus appeared in supernatants from day 10 (Fig. 2) . Virus titres in precultivated BMC were only 10~o of titres obtained in HEL cells and in general did not exceed 2 x l05 p.f.u./ml. Furthermore, virus replication in BMC showed a delay of approx. 8 days as compared to that in HEL cells (Fig. 2) . Freshly isolated BMC, however, did not show any virus replication upon infection with HCMV AD169. Thus, it appeared possible that the virus replication observed was not due to replication of HCMV AD 169 in these cells, but might reflect the activation of latent virus from the bone marrow cells. This, however, seemed unlikely for two reasons. First, mock-infected control BMC did not show any virus replication (Fig. 2) , and second the BMC we used were obtained from children under 5 years of age, who were HCMVseronegative by ELISA (data not shown).
In order to determine whether the observed delay in the increase of virus titres in BMC was indeed due to a delayed infectious cycle of HCMV, we compared viral protein and DNA synthesis in infected BMC and HEL cells. Results of these studies are presented in Fig. 3 . From SDS-PAGE analysis it was evident that 8 days after infection HEL cells express HCMV late proteins with relative molecular weights of 132K, 120K, 68K, 52K and 31K. These proteins probably correspond to the proteins gp 132, gp 120, vp68, gp55 and vp32 as described by Stinski (1977) . From the relative intensity of the bands it is likely that the 68K protein represents the major capsid protein of HCMV, whereas the 52K protein might represent the major virion glycoprotein (Farrar & Oram, 1984; Nowak et al., 1984) . In BMC cells, however, expression of these proteins was not observed before 16 days after infection, whereas 8 days after infection a 72K protein was identified which might correspond to an early protein of HCMV (Stinski et al., 1981 (Fig. 3b) . Virtually no background hybridization was observed in these experiments when mock-infected HEL or BMC were tested. The relatively strong hybridization signal obtained in HCMV-infected HEL and BMC immediately after infection (zero time point) may thus indicate the presence of input virus. Taken together these data indicate that HCMV in BMC replicates more slowly than in HEL cells. of only a subset of BMC by HCMV. Thus in order to determine virus production by BMC and HEL cells, infectious centre assays and indirect immunofluorescence experiments on HCMVinfected BMC and HEL cells were performed. As presented in Table 1, The fact that the replication of HCMV in BMC is restricted to a cell subset not exceeding 20 of the cells is in accordance with the finding that the replication of HCMV is slower in BMC than in HEL cells. It may also underline the persistence of HCMV infection in BMC which was observed over a period of 3 months (Fig, 4) . This persistence was characterized by the continuous production of infectious progeny virus over the whole time, at titres of approximately 105 p.f.u./ml.
days after infection, this level was not observed in BMC until day 12
As described above, virus titres in BMC in general were lower than in HEL cells. This might indicate either a lower production of progeny virus per cell by BMC or the productive infection
The observation that only a subset of BMC actively produced infectious progeny virus raised the question as to the nature of this subset. As described above, BMC cultures consisted of a variety of cell types. Among these are bone marrow stem cells, bone marrow fibroblasts and cellular elements of the peripheral blood. Thus, in an attempt to identify the HCMV-susceptible cell subsets among these different cell populations, we separated these cellular subpopulations by a preparative technique combining the use of plastic adherence and indirect rosetting with the monoclonal antibody OKT 10. This antibody was earlier described to recognize human bone marrow stem cells (Crawford et al., 1981 ; Greaves, 1981) . As a result of these experiments, we obtained three different cell cultures consisting of relatively pure bone marrow fibroblasts (Fig.  5 c) , OKT 10 + bone marrow stem cells (Fig. 5 a) and O K T 10-cells (not shown) as determined by cell morphology and indirect immunofluorescence (Table 1) . Upon separate infection of these cell populations with H C M V AD169 a c.p.e, was observed in bone marrow fibroblasts and OKT10 + cell cultures (Fig. 5b, d ), but not in OKT10-cells. Consistent data were obtained when virus production was determined by plaque assay as shown in Fig. 6 . Accordingly, infectious progeny virus was produced in bone marrow fibroblast and OKT10 ÷ cell cultures, the latter, however, producing lower amounts of virus. Again, OKT10-cells did not produce any measurable amounts of progeny virus, Replication of H C M V in fibroblasts and OKT10 + cells appeared to be delayed in comparison to H E L cells. This was also reflected by immunofluorescence data and by the fact that in infectious centre assays bone marrow fibroblasts showed 78 ~ positive cells, whereas OKT 10 + cells showed 24 ~ infectious centres and OKT10-cells were virtually negative (Table l) . To further confirm the true stem cell nature of the OKT10 ÷ cells, we have added a further experiment in which we infected OKT10-and OKT3 + peripheral blood T cells with HCMV. As had been expected, these cells did not produce any infectious progeny virus (Table 1) Einhorn & Ost (1984) show expression of HCMV early antigen in freshly isolated BMC and BMC held in culture for 6 days, but do not demonstrate any appreciable virus replication. In line with these results, we too could not demonstrate any replication of HCMV in freshly isolated BMC, but found appreciable virus replication with typical c.p.e, in BMC pre-cultivated for 3 weeks. This finding may indicate that in order to obtain virus replication in these cells a certain cellular differentiation step may be necessary, as recently described by G6ncz61 et al. (1984) for the replication of HCMV in human embryonal carcinoma cells and by Daniels et al. (1978) for the replication of herpes simplex virus in human macrophages. Assuming the BMC to be a possible site of viral latency, it seemed possible that the observed titre rises were due to reactivation of latent virus by prolonged cultivation of BMC. This, however, was unlikely since we did not observe any titre rises in mock-infected BMC cultures and since the bone marrow donors were HCMV seronegative by ELISA. Furthermore, a typical HCMV c.p.e, with inclusion bodies was observed in the infected BMC.
It was observed that BMC in comparison to HEL cells produced lower amounts of infectious virus and showed some delay in the infectious cycle. This finding may be due to the fact that infection of BMC with HCMV involved primarily only a few susceptible cells producing virus and that during the time of the infectious cycle more and more cells reach a differentiation stage at which they become permissive for infection by the progeny virus from initially infected cells. The possibility of such a virus-cell interaction was also supported by the low percentage of infectious centres found in BMC and would result in a balance between outgrowing cells and virus-producing cells which may also explain our finding of a short-term persistence of the virus in such BMC cultures. A similar delay in virus replication and the establishment of a short-term persistence has been recently described for the replication of HCMV in human smooth muscle cells (Tumilowicz et al., 1985) .
The low percentage of virus-producing cells in BMC cultures, however, made it important to determine the nature of the viral target cell in BMC. By experiments with preparatively separated BMC subpopulations it was shown that HCMV replicated well in the fibroblast and OKT10 + cells, but not in the OKT10-cell fraction. This was documented by the demonstration of c.p.e., titre rises, infectious centre assays and indirect immunofluorescence. There were, however, contradictory results between these assays; for instance 24~o of OKT10 + cells were positive by infectious centre assay, but 45 ~ were positive for immunofluorescence using an antiserum to HCMV late antigen. This might be explained if either some of the OKT10 + cells and also of the bone marrow fibroblasts had non-specifically adsorbed viral particles to their surface, or if under infectious centre assay conditions they did not produce infectious particles. A further difference was observed in the percentage of infectious centres formed by unseparated BMC (21~), and formed by bone marrow fibroblasts (78~o) and OKTI0 ÷ cells (24~o). In this context it should be noted that OKT10-cells were virtually negative in infectious centre assays, and thus the percentage of infectious centres formed in BMC results from the mixture of these three different cell populations. From the finding that peripheral blood T cells under these conditions do not show any appreciable virus replication (Table 1) (1984) have shown that replication of HCMV in primary human lymphocytes and monocytes is restricted to the expression of immediate early gene products and that wild-type isolates of HCMV have a higher capacity to express such gene products than laboratory strains. Though we did not prove the ability of wild-type strains to replicate in BMC, it is likely that such strains may show replication characteristics different from the AD169 strain which has been adapted to HEL or HFF cells over many years.
In conclusion, we have shown that HCMV may replicate in primary human BMC under certain conditions and that this replication involves both bone marrow fibroblasts and OKT10 + stem cells.
